Bile Duct Cancer: New Molecular Test Doubles Detection Rate
A new molecular test, BiliSeq, developed by researchers at UPMC Hillman Cancer Center and the University of Pittsburgh School of Medicine, is poised to significantly improve the early and accurate diagnosis of bile duct cancer – a malignancy historically plagued by diagnostic delays and inaccuracies. This isn’t simply an incremental improvement; the test nearly doubles … Read more